Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine for post-operative ileus after colorectal surgery
ACTRN12621000530820Phase 3Recruiting
- Sponsor
- University of Adelaide
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pyridostigmine in postoperative ileus (POI), sponsored by University of Adelaide. Started Oct 2021; status: recruiting.
02
Drugs
pyridostigmine
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on ACTRN12621000530820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000530820.